Page last updated: 2024-12-11
beta casomorphin 4027
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 5464104 |
| CHEMBL ID | 2106384 |
| SCHEMBL ID | 1373200 |
| SCHEMBL ID | 22634048 |
| MeSH ID | M0136131 |
Synonyms (22)
| Synonym |
|---|
| beta casomorphin 4027 |
| casokefamide |
| (2s)-2-amino-n-[(2r)-1-[[(2s)-1-[[(2r)-1-[[(2s)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide |
| casokefamidum |
| casokefamidum [inn-latin] |
| casokefamida [inn-spanish] |
| 98815-38-4 |
| casokefamida |
| casokefamide [inn] |
| unii-b453t1e8mp |
| b453t1e8mp , |
| l-tyrosyl-d-alanyl-l-phenylalanyl-d-alanyl-l-tyrosinamide |
| CHEMBL2106384 |
| SCHEMBL1373200 |
| tyr-d-ala-phe-d-ala-tyr-nh2 |
| l-tyrosinamide,l-tyrosyl-d-alanyl-l-phenylalanyl-d-alanyl-(9ci) |
| DTXSID30243827 |
| AKOS027383018 |
| Q5048995 |
| (s)-2-amino-n-((r)-1-((s)-1-((r)-1-((s)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-yl)-3-(4-hydroxyphenyl)propanamide |
| (s)-2-amino-n-((r)-1-(((s)-1-(((r)-1-(((s)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)-3-(4-hydroxyphenyl)propanamide |
| SCHEMBL22634048 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.37
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (16.67%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||